Amazon Pharmacy expands drone delivery service to prescription medications
By
Kimberly Bonvissuto
Oct 20, 2023
Older adults in one Texas town looking to simplify their medication management might be able to have prescriptions delivered via drone.
Nurse practitioners no more likely than doctors to prescribe inappropriately
Oct 23, 2023
Nurse practitioners were overrepresented among clinicians with the highest and lowest rates of inappropriate prescribing.
Medically advised aspirin use lower in 2021 than 2012 to 2017
Jun 24, 2024
Compared with 2012 to 2017, in 2021, medically advised aspirin use for primary prevention was lower (19.3 versus 27.6 to 31.2% among adults aged 60 to 69 years; 30.6 versus 38.35 to 41.6% among those aged...
Doxycycline tied to lower risk for C. difficile in pneumonia patients
Nov 30, 2023
The incidence of C. difficile infection was reduced by 45% with doxycycline among patients with a prior history of CDI.
Ketamine no better than placebo for depression
Oct 25, 2023
Intravenous ketamine delivered during surgical anesthesia has no greater effect than placebo in reducing severity of depression.
Antihypertensives linked to eczematous dermatitis in seniors
May 24, 2024
The largest effect sizes were seen for diuretics and calcium channel blockers, and the smallest were seen for ACE inhibitors and beta-blockers.
Minocycline does not decrease geographic atrophy enlargement in AMD
Mar 25, 2024
The GA enlargement rate in the study eyes did not differ significantly in the run-in and treatment phases in age-related macular degeneration.
Lixisenatide reduces motor disability progression in Parkinson’s disease
Apr 04, 2024
Lixisenatide results in less progression of motor disability than placebo at 12 months for individuals with early Parkinson’s disease.
Oral switch noninferior for low-risk S. Aureus bloodstream infection
Jan 26, 2024
Early oral antimicrobial therapy was noninferior to intravenous standard therapy for low-risk bloodstream infection.
Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.